Open AccessSleeping through a pandemic: impact of COVID-19–related restrictions on narcolepsy and idiopathic hypersomnia
Author(s) -
Milan Nigam,
Amandine Hippolyte,
Pauline Dodet,
Ana Gales,
JeanBaptiste Maranci,
Saba Al-Youssef,
Smaranda LeuSemenescu,
Isabelle Arnulf
Publication year - 2021
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.9556
Subject(s) - narcolepsy , medicine , covid-19 , pandemic , modafinil , psychiatry , virology , disease , outbreak , infectious disease (medical specialty)
To assess the impact of coronavirus disease 2019 (COVID-19)-related restrictions on narcolepsy type 1 (NT2), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom